SISCAPA Assay Technologies develops immunoassays for the quantitation of protein biomarkers and targets.
SISCAPA Assay Technologies has raised $2.0M in total funding. The most recent round was Undisclosed. The last funding was announced in July 2025.
SISCAPA Assay Technologies is headquartered in Washington, United States.
SISCAPA Assay Technologies develops immunoassays for the quantitation of protein biomarkers and targets.
SISCAPA Assay Technologies is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SISCAPA Assay Technologies — Funding & Investors." VCBacked, July 3, 2025, https://www.vcbacked.co/company/siscapa-assay-technologies. Accessed October 4, 2026.
VCBacked. (2025). SISCAPA Assay Technologies — Funding & Investors. Retrieved October 4, 2026, from https://www.vcbacked.co/company/siscapa-assay-technologies
{{cite web |title=SISCAPA Assay Technologies — Funding & Investors |url=https://www.vcbacked.co/company/siscapa-assay-technologies |website=VCBacked |access-date=October 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated